LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹525 Cr | ₹463 Cr | ₹391 Cr | ₹373 Cr | ₹328 Cr |
What is the latest Total Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹525 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹391 Cr |
| Mar2022 | ₹373 Cr |
| Mar2021 | ₹328 Cr |
How is Total Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹525 Cr | 13.37 | |
| Mar2024 | ₹463 Cr | 18.37 | |
| Mar2023 | ₹391 Cr | 4.83 | |
| Mar2022 | ₹373 Cr | 13.85 | |
| Mar2021 | ₹328 Cr | - | |
Compare Total Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,187.2 Cr | -3% | -3.6% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3% |
-3.6% |
14.1% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses